Recorded on 05/29/25

TD Cowen analyst Shaul Eyal speaks with Cellebrite's Andrew Kramer, VP of IR, from TD Cowen's 53rd Annual TMT conference about the company's tailwinds, technology, and business model, as well as current market trends as the company remains focused on driving double-digit growth and profitability.  Cellebrite is a rule of 45 company. Additionally, we address the competitive landscape, which remains largely intact given what we view as high barriers of entry. We continue to view Cellebrite as benefitting from a sizable >$15B TAM opportunity as its SaaS offering and its expanding platform support healthy adoption by its current customer base. We also address Cellebrite's enterprise opportunity as well as recent management changes and discuss cash utilization strategies.

https://go.td.com/PodcastDisclosure